Liberty Bell Report
Conservative news from the nation’s capital
Bayer's Sunharbo, the first approved drug in a new class called factor XIa inhibitors, cut the rate of repeat ischemic strokes by about a quarter in a large trial without a significant rise in major bleeding. Here is who it is for, what it costs and what doctors say to watch for.
Lilly's Foundayo pill eased sleep apnea and its experimental shot retatrutide cut knee pain, but cost, coverage and side effects remain key questions for seniors.
The agency is requiring labels on drugs like Ozempic, Wegovy and Zepbound to flag a rare optic nerve condition, even as new studies point to other benefits.
“Proclaim liberty throughout all the land”
Welcome, patriotReal news, faith and freedom from the nation’s capital. Join free and stand with a newsroom that answers to you, not to Washington.
Free, always. We never sell your email.
